Transgene Market Cap

Transgene has a market cap or net worth of €87.11 million as of April 1, 2025. Its market cap has decreased by -25.33% in one year.

Market Cap

87.11M

Enterprise Value

80.66M

Revenue

6.35M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.67

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 87.11M, a decrease of -42.64%. That is a compound annual growth rate of -2.04%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	87.11M	-2.94%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	126.57B
EssilorLuxottica Société anonyme	121.76B
Sartorius Stedim Biotech	18.06B
bioMérieux	13.73B
Eurofins Scientific SE	9.39B
Ipsen	8.84B
Virbac	2.52B
emeis Société anonyme	1.76B

Market Cap Rankings